Natco launches drug for bone disease
Natco Pharma Ltd on Tuesday said it has launched Ibandronate Sodium, a drug used in the treatment of metastatic bone disease, in tablet and injection forms.
By PTI |
MUMBAI: Natco Pharma Ltd on Tuesday said it has launched Ibandronate Sodium, a drug used in the treatment of metastatic bone disease, in tablet and injection forms.
The drug is priced at Rs 2,500 per 6 mg injection and at Rs 49 per 50 mg tablet, against the price of imported versions of Rs 13,500 per injection and Rs 600 per tablet.
It has been launched under the brand name, Bandrone, the company informed the Bombay Stock Exchange.
The drug is priced at Rs 2,500 per 6 mg injection and at Rs 49 per 50 mg tablet, against the price of imported versions of Rs 13,500 per injection and Rs 600 per tablet.
It has been launched under the brand name, Bandrone, the company informed the Bombay Stock Exchange.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
